论文部分内容阅读
目的探讨铝碳酸镁联合莫沙必利治疗胆汁反流性胃炎的疗效。方法 120例患者随机分为治疗组和对照组各60例,对照组给予常规多潘立酮和硫糖铝对症治疗,治疗组应用铝碳酸镁和莫沙必利治疗。观察2组的临床疗效及复发情况。结果治疗组有效率为88.3%,高于对照组的73.3%,治疗组6个月、1年的复发率低于对照组,差异有统计学意义(P<0.05)。结论铝碳酸镁联合莫沙比例治疗胆汁反流性胃炎疗效显著,复发率低,安全方便,值得临床推广应用。
Objective To investigate the curative effect of aluminum magnesium carbonate combined with mosapride on bile reflux gastritis. Methods 120 patients were randomly divided into treatment group and control group of 60 cases, the control group were given conventional domperidone and sucralfate symptomatic treatment, the treatment group with magnesium aluminum carbonate and mosapride treatment. The clinical efficacy and recurrence of the two groups were observed. Results The effective rate of the treatment group was 88.3%, which was higher than that of the control group (73.3%). The recurrence rate of the treatment group for 6 months and 1 year was lower than that of the control group (P <0.05). Conclusion The treatment of bile reflux gastritis with aluminum magnesium carbonate combined with Mosha proportion has obvious curative effect, low recurrence rate, safe and convenient, and is worthy of clinical application.